
BlueTree Allied Angels
Description
BlueTree Allied Angels is a prominent angel investment group based in Wexford, Pennsylvania, serving the greater Pittsburgh region and beyond. Established in 2003, the group comprises accredited investors primarily from Western Pennsylvania who are dedicated to fueling the growth of early-stage companies with high potential. Their investment philosophy centers on identifying innovative ventures that demonstrate strong management teams, proprietary technology, and a clear path to market success and eventual exit.
The group primarily targets companies in the Seed and Series A stages, providing crucial capital to help these businesses scale. BlueTree Allied Angels typically deploys initial investments ranging from $250,000 to $1,000,000, often participating in syndicates with other angel groups or venture capital firms to provide larger funding rounds. Beyond initial checks, they also engage in follow-on rounds to support their portfolio companies through subsequent growth phases, demonstrating a long-term commitment to their investments.
Since its inception, BlueTree Allied Angels has made a significant impact on the regional startup ecosystem. The group has collectively invested over $60 million across more than 100 companies, showcasing their active role in fostering innovation and economic development. Their diverse portfolio spans various high-growth sectors, including life sciences, software, advanced manufacturing, and consumer products, reflecting a broad interest in disruptive technologies and scalable business models. BlueTree's members often provide not just capital, but also strategic guidance, mentorship, and access to their extensive professional networks, adding substantial value to the ventures they support.
Investor Profile
BlueTree Allied Angels has backed more than 37 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 16% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (30%)
- Series A (24%)
- Series B (16%)
- Series Unknown (14%)
- Angel (5%)
- Pre Seed (5%)
- Convertible Note (3%)
- Series C (3%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Therapeutics
- Medical Device
- Information Technology
- Life Science
- Artificial Intelligence (Ai)
- Enterprise Software
- Medical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.